MJMarzieh Jamalidoust

Marzieh Jamalidoust

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marzieh Jamalidoust has a total of 124 co-authors. Here are the top co-authors by number of shared publications:

  • Mazyar Ziyaeyan

    Department of Clinical Virology, Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Namazi Hospital, Shiraz, Iran

    20 shared publications
  • Gholamreza Pouladfar

    Professor Alborzi Clinical Microbiology Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    12 shared publications
  • Nasrin Aliabadi

    Department of Clinical Virology, Clinical Microbiology Research Center Shiraz University of Medical Sciences, Namazi Hospital Shiraz Iran

    11 shared publications
  • Mahsa Moeini

    Department of Virology, Professor Alborzi Clinical Microbiology Research Center, Nemazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran

    6 shared publications
  • Mazyar Ziyaeyan

    Department of Virology, Professor Alborzi Clinical Microbiology Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    5 shared publications
  • Nahid Heydari Marandi

    Department of Virology, Professor Alborzi Clinical Microbiology Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    5 shared publications

Latest Publications

  • Open Access

    Design and Evaluation of Innovative Loop-Mediated Isothermal Amplification-Lateral Flow Dipstick Kits for Advanced Detection of HPV16 and HPV18

    by Farzane Kargar, Mohammad Rahmati, Marzieh Jamalidoust, Mojtaba Mortazavi, Amir Savardashtaki, Morteza Milani, Amir Vahedi

    Background: Cervical cancer is a major cause of cancer-related mortality among women worldwide. Existing human papillomavirus (HPV) detection methods, such as PCR and immunohistochemistry (IHC), face barriers related to cost, infrastructure, and accessibility. Loop-mediated isothermal amplification (LAMP), a rapid, thermocycler-free nucleic acid amplification technique, combined with lateral flow dipstick (LFD) readout, enables simple, visual DNA detection. Objectives: This study developed and evaluated a novel LAMP-LFD assay to improve the detection of high-risk HPV16/18 in clinical specimens, with the aim of providing a rapid, sensitive, and user-friendly diagnostic tool for use in local healthcare settings. Methods: Cervical specimens were collected from women attending a gynecology clinic who were clinically suspected of having HPV16/18 infection, and DNA was extracted. HPV16/18 presence was initially confirmed by real-time PCR, which served as the reference standard for HPV16/18 detection. Subsequently, LAMP reactions using HPV16/18-specific primers were performed, and amplification products were detected using a molecular LFD system with gold-labeled antibodies. The same DNA samples were then analyzed using the LAMP-LFD assay. The sensitivity and specificity of the LAMP-LFD assay were compared with those of standard PCR methods. Diagnostic performance (sensitivity, specificity, predictive values, accuracy, and Cohen's kappa) was calculated by comparing LAMP-LFD results with real-time PCR. Included samples had adequate volume and acceptable DNA purity (A260/280 ratio: 1.8 - 2). All participants provided written informed consent. Exclusion criteria included sample contamination, insufficient volume, low-quality DNA, lack of signed consent, or failure to meet quality control standards to ensure sample integrity and reproducibility. Agreement between the LAMP-LFD assay and PCR was assessed using Cohen’s kappa coefficient, with 95% confidence intervals calculated. Results: Among the 50 clinical specimens, real-time PCR identified 20 HPV-positive and 30 HPV-negative specimens. Compared with PCR, the LAMP-LFD assay detected all PCR-positive samples but yielded two false-positive results for HPV16, resulting in high sensitivity (100%) and good specificity (93.3%). The specificity of the LAMP-LFD assay was also high, with minimal cross-reactivity observed between HPV16 and HPV18 targets. Compared with conventional PCR, the LAMP-LFD assay provided a faster turnaround time, required less specialized equipment, and was suitable for point-of-care applications. The sensitivity of LAMP is similar to or better than that of PCR (101 to 103 copies). LAMP specificity varies (67.5%-99.2%) and can be lower than that of PCR. Overall, the LAMP-LFD assay demonstrated 100% sensitivity and 93.3% specificity compared with real-time PCR. Conclusions: The developed LAMP-LFD assay is a rapid, sensitive, and user-friendly method for detecting high-risk HPV16 and HPV18 genotypes in clinical specimens. This approach has the potential to enhance HPV screening and cervical cancer prevention, particularly in resource-limited settings where access to conventional molecular diagnostics is restricted. The implementation of LAMP-LFD technology could facilitate timely diagnosis and management of HPV-associated diseases in local hospitals and field studies.

  • Open Access

    Trends in Pediatric Respiratory Viral Infections in Southwest Iran Following the COVID-19 Pandemic (2022 - 2023 Cold Season)

    by Marzieh Jamalidoust, Marzieh Hosseini, Mandana Namayandeh, Seyedeh Sedigheh Hamzavi, Mohammad Rahim Kadivar

    Background: Respiratory viral infections changed substantially during the COVID-19 pandemic. Evaluating post-pandemic viral circulation is important to understand the resurgence and clinical patterns of common pediatric respiratory viruses. Objectives: This study aimed to determine trends in viral respiratory infections and their associated clinical symptoms during the cold season at the end of the COVID-19 pandemic in Iran. Methods: A total of 1,530 respiratory samples from hospitalized children diagnosed with acute respiratory infections were included. Demographic characteristics and clinical signs and symptoms were recorded. A multiplex real-time polymerase chain reaction assay was used to detect common respiratory viruses, including SARS-CoV-2, influenza, respiratory syncytial virus, and rhinovirus, in patient samples collected from October 2022 to April 2023. Results: Among 1,530 hospitalized children with respiratory symptoms, 36.3% had at least one viral detection. Influenza was the most frequently identified virus (11.3%), followed by respiratory syncytial virus (10.5%), SARS-CoV-2 (9.8%), and rhinovirus (4.7%). Most infections occurred in children younger than 2 years, with a peak incidence in January. Coinfections were infrequent and most commonly involved rhinovirus. Influenza and respiratory syncytial virus infection rates were significantly higher in children aged ≥ 3 years and < 3 years, respectively. However, COVID-19 and rhinovirus infection rates did not differ significantly among age groups. Clinical presentations varied across viral groups. Conclusions: Given changes in health guidelines and waning antibody levels, it is important to examine the behavior and frequency of respiratory viruses in the post-COVID-19 period. This study demonstrated the resurgence of influenza and respiratory syncytial virus following the pandemic.

  • Open Access

    Identification of the SARS-CoV-2 Genome in Various Systemic Samples from the Laboratory of Confirmed COVID-19 Patients in Iran

    by Marzieh Hosseini, Nasrin Aliabadi, Azita Tabatabai Esfehani, Amin Abbasian, Solmaz Salami, Samaneh Eizadpanah, Marzieh Jamalidoust

    Background: COVID-19 is a highly contagious respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While nasopharyngeal swab testing remains the primary method for identifying SARS-CoV-2 carriers, the virus’s genetic material can be detected in various bodily samples, suggesting potential transmission through non-respiratory routes. Objectives: This study aimed to investigate the presence and quantity of SARS-CoV-2 RNA in stool, endotracheal tube (ETT) samples, cerebrospinal fluid (CSF), bronchoalveolar lavage (BAL), and sputum. The research sought to correlate these findings with clinical characteristics and the severity of illness. Methods: We retrospectively collected 1,567 samples, including 550 BAL samples, 464 ETT samples, 45 fecal samples, 21 CSF samples, and 487 sputum samples from patients admitted to Namazi Hospital between April 1, 2020, and the end of September 2022. Clinical characteristics, patient demographics, radiographic, and laboratory results were among the medical data gathered and assessed. We used reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect and measure SARS-CoV-2 RNA shedding in different samples of individuals infected with COVID-19. Results: Among the 550 BAL samples collected from patients, 20.7% tested positive for SARS-CoV-2. Additionally, the virus’s genome was detected in 17.8% of 45 CSF samples, 11% of 464 ETT samples, 4.76% of 21 fecal samples, and 2.9% of 487 sputum samples. Notably, patients with SARS-CoV-2-positive BAL samples exhibited a significantly higher frequency of cough and dyspnea than those who tested negative. Conclusions: These findings revealed that SARS-CoV-2 has been detected in diverse specimens collected from the upper and lower respiratory systems (sputum, ETT, and BAL samples), the central nervous system (CSF), and the digestive tract (fecal samples) during the infection’s progression. This widespread presence significantly impacts our understanding of the disease’s pathogenesis and enhances diagnostic capabilities, proving a valuable asset in managing the infection.

  • Open Access

    Identification of Viral Causes in Cerebrospinal Fluid of Patients Under Investigation for Central Nervous System Infections During the COVID-19 Epidemic: A Cross-Sectional Study

    by Nasrin Aliabadi, Nahid Heydari Marandi, Gholamreza Pouladfar, Seyedeh Sedigheh Hamzavi, Marzieh Hosseini, Rosemina Bahrololoom, Marzieh Jamalidoust, Mazyar Ziyaeyan

    Background: Although viral etiology of central nervous system (CNS) infections such as meningitis and encephalitis are investigated widely worldwide, it remains to be declared under the COVID-19 pandemic. Objectives: The focus of this study was to examine the etiology of viral CNS infections in patients hospitalized in a single referral hospital during the outbreak in Iran. Methods: We retrospectively collected the cerebrospinal fluid (CSF) samples and reviewed the medical records of patients hospitalized with suspected viral CNS infection in Shiraz, a large city in southern Iran, from April 2021 to May 2022. One hundred sixty-six CSF samples were tested primarily for detection of HSV-1 and -2 and retrospectively analyzed by primers polymerase chain reaction (PCR) targeted to coronavirus 2 (SARS-CoV-2), human herpesviruses1 to 6 (HHV-1 to 6), polyomaviruses JC, and enteroviruses (EV). Results: Of the total CSF samples analyzed by PCR, 22 (13.3%) were positive for only one viral pathogen, and just one (0.6%) sample was detected with multiple viruses (HSV-1 and CMV). The SARS-CoV-2 (6 cases) was the second most common viral etiology just after Herpes simplex virus-1 (HSV-1) 6.6% (11 cases). Other detected viruses were CMV for 1.8% (3 cases), VZV for 1.2% (2 cases), and JC for 0.6% (1 case) of the cases. Conclusions: This study highlights the prevalence of viral pathogens in CSF samples from patients with suspected meningitis at Namazi Teaching Hospital. Notably, HSV-1 was the most common virus detected, followed by SARS-CoV-2. These findings underscore the importance of viral testing in the diagnosis and management of meningitis.


  • Open Access

    Human Papillomavirus Prevalence in Urine and Anatomical Sites in South Iranian Men and Women with Normal and External Genital Warts: A Cross-Sectional Study

    by Nasrin Aliabadi, Nahid Heydari Marandi, Gholamreza Pouladfar, Marzieh Hosseini, Zahra Shiravani, Marzieh Jamalidoust, Naeimehossadat Asmarian, Ali Faramarzi, Hossain Faramarzi, Mazyar Ziyaeyan

    Background: Human papillomavirus (HPV) is the most prevalent sexually transmitted infection, especially among sexually active individuals. Objectives: This study aimed to determine the prevalence of HPV infection among males and females in Southern Iran. Although previous studies have explored HPV prevalence in various provinces across Iran, this research is unique as the first to examine a four-type sample within this region. Methods: This cross-sectional study involved a sample of residents from Southern Iran, comprising 82 females (71.9%) and 32 males (28.1%), aged between 13 and 74 years, most of whom were sexually active. The main focus of the research was to investigate HPV infection across various anatomical sites in both healthy women and those with external genital warts (eGW). Results: The anatomical sites assessed included the oral, anal, vaginal, and urinary areas. Out of the total sample, 79 individuals (69.3%) tested positive for HPV. Within this group, 65 individuals (81.3%) were from the eGW group, while 14 individuals (41.2%) belonged to the normal population. A statistically significant difference (P ≤ 0.1) was observed in the prevalence of HPV in oral samples between the two groups. In the eGW group, 61 participants were positive for low-risk HPV (LR-HPV) genotypes, and 4 tested positive for HPV-18. Among the normal population, 14 individuals tested positive for LR-HPV genotypes. Notably, a higher proportion of positive HPV results—approximately 29%—was identified in anal and urinary samples compared to vaginal samples from females in the normal population. Conclusions: Significant differences in HPV prevalence were noted between individuals with eGW and those in the normal population. Overall, the prevalence of HPV among eGW individuals was approximately twice that of the normal population across the four anatomical sites. Further research is warranted to better understand the association between HPV infection, eGW, and various sociodemographic factors.

  • Open Access

    Etiology of Severe Acute Respiratory Infections in ICU-Admitted Patients During the COVID-19 Pandemic in Iran: A Single Center Study

    by Marzieh Jamalidoust, Gholamreza Pouladfar, Maryam Eskandari, Nasrin Aliabadi, Nahid Heydari Marandi, Mandana Namayandeh, Mazyar Ziyaeyan

    Background: Acute respiratory infections (ARI) caused by a wide range of etiologies represent a significant public health challenge worldwide. Objectives: In this study, we aimed to evaluate the characteristics of ARI caused by various respiratory pathogens among patients admitted to intensive care units (ICUs) in a referral hospital in Iran during the first four waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Methods: A total of 395 patients with ARI were enrolled, all hospitalized in the ICUs of Nemazi Teaching Hospital, affiliated with Shiraz University of Medical Sciences in Shiraz, Iran, over a 13-month period from April 2020 to June 2021. Real-time polymerase chain reaction (RT-PCR) assays were used to detect SARS-CoV-2, influenza viruses, respiratory syncytial virus (RSV), Mycoplasma, and Chlamydia in nasopharyngeal fluid (NPS) samples. The demographic and clinical data, including underlying diseases, were also considered. Results: Of the 395 patients, 209 (53.7%) were male, and the mean age was 32 ± 27 years. An etiology was detected in 63 (16%) patients, with 53 testing positive for SARS-CoV-2 and 5 each for Chlamydia and Mycoplasma. No RSV or influenza infections were detected. The highest rate of COVID-19 was observed among adults aged 36 to 65 years (5.31%), while the lowest rate was in children under 5 years old (0.3%). Shortness of breath was the most common symptom in SARS-CoV-2-infected patients (P-value ≤ 0.001). Of the total patients, 146 (37%) had at least one underlying disease, with diabetes being the most common (8.1%). Conclusions: The absence of RSV and influenza infections, along with a notable number of Chlamydia and Mycoplasma infections during the first four waves of the SARS-CoV-2 pandemic, emphasizes the importance of continuous surveillance of the etiologies of ARI during respiratory pandemics. This information is critical for guiding appropriate infection control measures and selecting empirical antibiotic regimens.


  • Open Access

    Human Papillomavirus (HPV16 and HPV18) Infection; Pathogenesis, Vaccination, and Detection by Loop-Mediated Isothermal Amplification with Lateral Flow Dipstick Tests: A Review

    by Farzane Kargar, Mohammad Rahmati, Marzieh Jamalidoust, Mojtaba Mortazavi, Amir Savardashtaki, Morteza Milani, Amir Vahedi

    Context: Human papillomavirus (HPV) infections contribute to the cause of 15% - 20% of all human cancers. This review aims to examine and provide updated information on various aspects, with a particular focus on topics that are of interest to dermatologists. Evidence Acquisition: Using published studies, the pathogenicity of HPV was investigated. Subsequently, the existing vaccines were explored, followed by a review of the loop-mediated isothermal amplification-lateral flow dipstick (LAMP-LFD) method. Results: For HPV detection, the polymerase chain reaction (PCR), self-sustained sequence replication (3SR), strand displacement amplification (SDA), and nucleic acid sequence-based amplification (NASBA) were used. These methods can have good detection but still have problems. In comparison with nested PCR, the detection of HPV16 and HPV18 using LAMP-LFD has higher sensitivity. Conclusions: Loop-mediated isothermal amplification-lateral flow dipstick is a simple and rapid method for the specific and sensitive detection of HPV. Thus, along with the previous HPV16 and HPV18 diagnostic tools, LAMP-LFD might be useful in field studies or local hospitals.


  • Open Access

    A Comparative Study of the Diagnostic Value of Once and Twice Nasopharyngeal, Oropharyngeal, and Anal Swabs, and Saliva Specimens in COVID-19 Infection

    by Anahita Sanaei Dashti, Amir Hossein Hassani, Maryam Mohammadrezaee, Masoud Najafi, Azita Tabatabai Esfehani, Mandana Namayandeh, Soulmaz Salami, Samaneh Eizadpanah, Marzieh Jamalidoust

    Background: Since the emergence of COVID-19 and the pandemic declaration, this disease has become the top priority for global healthcare systems. The standard diagnostic tool for COVID-19 involves conducting imaging studies alongside real-time polymerase chain reaction (RT-PCR) tests on nasopharyngeal or oropharyngeal samples. Objectives: Given the potential extrapulmonary involvement of COVID-19, our objective was to evaluate the diagnostic effectiveness of double pharyngeal sampling, as well as the use of saliva and anal swabs. Methods: This cross-sectional study involved 102 pediatric patients suspected of having COVID-19. After the routine nasopharyngeal sampling, additional samples were collected from the nasopharynx, saliva, and anal canal. These samples were subjected to RT-PCR testing using Taq Man's probe-based technology. The statistical analysis included sensitivity, specificity, positive and negative predictive values, and Kappa agreement measurement. Results: In this study, with a COVID-19 prevalence of 92.2%, we compared the diagnostic efficacy of different methods. When having at least one positive sample was considered the gold standard, double nasopharyngeal sampling exhibited the highest sensitivity, followed by RT-PCR of saliva and anal swabs (94.9%, 92.9%, and 91.9%, respectively). When double sampling was considered the gold standard for diagnosis, saliva RT-PCR showed the highest sensitivity and negative predictive value (93.6% and 40.0%, respectively). However, there was no significant difference in the specificity and positive predictive value between anal swabs and saliva RT-PCR. However, when anal swabs and saliva were compared with only one nasopharyngeal sample, anal swabs performed slightly better than saliva. Conclusions: While the combination of double sampling from the nasopharynx and oropharynx, along with anal swabs and saliva, proved effective for diagnosing COVID-19, routine use of these methods may not be cost-effective. However, during periods of epidemic control, when comprehensive case identification is crucial, these methods may warrant consideration for more extensive investigations.

  • Open Access

    Molecular, Immunological, and Clinical Characterization of SARS-CoV-2 Infection in Breakthrough-Infected Healthcare Workers During the Last Wave of The Pandemic in Shiraz, Iran

    by Sepideh Saeb, Gholam Reza Talei, Azam Ghaziasadi, Arash Letafati, Sayyad Khanizadeh, Marzieh Jamalidoust

    Background: The coronavirus disease 2019 (COVID-19) poses a threat to the global economy and public health. Mutations in the spike protein of the virus can impact the functional characteristics and effectiveness of vaccines. Objectives: This study aimed to analyze mutations in three key regions of the spike protein, investigate clinical presentations, and assess protective immune levels in healthcare workers (HCWs) who had received full vaccine doses but were re-infected. Methods: In this cross-sectional study, 49 breakthrough-infected HCWs were included from November 2021 to May 2022. After confirming COVID-19 reinfection, the SARS-CoV-2 genome was extracted using the ROJE extraction kit, and genetic variation analysis was performed through Sanger sequencing. Blood samples were collected with prior consent, and ELISA tests were performed to determine antibody levels. Clinical presentations were recorded, and independent t-tests revealed no significant gender-based differences in the C-terminal point mutation. Results: In this study, 75.5% (37/49) of the included HCWs were female (P-value < 0.05), and 25 were qualified for PCR and gene sequencing. Mutations were observed in 25, 10, and 1 sequence(s) of the C-terminal domain, N-terminal domain, and RBD regions of the S1 gene, respectively. The mutations had no significant correlation with the patient's gender, age, or occupation, but they were significantly more prevalent in those with underlying diseases. 63.3% (31/49) of patients had high or very high IgG levels, and none had undetectable antibody levels at the time of reinfection. Loss of the sense of smell (69.4% - 34/49), sore throat (65.3% - 32/49), headache (59.2% - 29/49), and cough (57.1% - 28/49) were the most prevalent clinical manifestations (P > 0.05) in breakthrough-infected HCWs, aligning with the pattern of symptoms seen in the Omicron wave. However, the loss of the sense of taste showed significant results concerning clinical manifestation (P < 0.05). The examination of mutations revealed the presence of the Omicron variant in the majority of individuals. Point mutations in the C-terminal region did not significantly vary based on age, gender, or vaccine type. No significant difference was observed between vaccine types and clinical symptoms. Conclusions: In conclusion, this study identified spike protein mutations in reinfections among vaccinated healthcare workers. While mutations were prevalent, no significant correlations were found with demographics or vaccine types. Symptoms resembled the Omicron variant, notably with the loss of the sense of taste as a significant marker. Detectable antibody levels post-reinfection suggest that vaccine-induced immunity remains robust. Continuous monitoring of virus variants is crucial for optimizing vaccination strategies in the face of evolving strains.

  • Open Access

    Association of IL-10 Gene in Protection Against COVID-19 Disease

    by Najmeh Sheikhi, Marzieh Jamalidoust, Arash Letafati, Kiana Shahzamani, Anahita Sanaei Dashti, Gholamreza Talei

    Background: The medical community is facing a new challenge with the coronavirus disease 2019 (COVID-19) pandemic, as the severity of the disease is largely determined by the overexpression of proinflammatory cytokines, leading to endothelial dysfunction and organ damage, especially in the lungs. Objectives: It is believed that mutations might be linked to severe illness. This cross-sectional study aimed to explore the correlation between COVID-19 severity in Iranian pediatric patients who were referred to Namazi Hospital (Shiraz, Iran) and interleukin 10 (IL-10) gene polymorphisms (rs1800896, rs1800871, and rs1800872). Methods: The study comprised 53 pediatric patients with COVID-19, who were divided into mild/moderate (n = 44) and severe (n = 9) groups. Nasal swabs and whole blood samples were collected from each patient who participated in the study. Real-time polymerase chain reaction (PCR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmation (E, RdRp) and PCR-restriction fragment length polymorphism (RFLP) were used for IL-10 gene polymorphism genotyping. Results: The study investigated the association between IL-10 gene polymorphisms and COVID-19 severity in pediatric patients. The results showed that the GA genotype at the IL10-1082 locus was protective against severe symptoms and that all severe cases were male with the AA/GA genotype. The other two loci, IL10-819 and IL-10-592, did not show any significant association with COVID-19 severity. The study also showed that shortness of breath was the only symptom significantly associated with COVID-19 severity and that age and gender did not affect the disease outcome. Conclusions: The most common symptoms in the mild/moderate group were cough and fever; however, shortness of breath and cough were the most common in the severe group. Coronavirus disease 2019 severity is related to the IL-10 (rs1800872) gene polymorphism, with the GA genotype providing protective effects.